# Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment

> **NCT01380262** · — · UNKNOWN · sponsor: **Maria Sklodowska-Curie National Research Institute of Oncology** · enrollment: 40 (estimated)

## Conditions studied

- Colorectal Cancer
- Skin Toxicities

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01380262
- **Lead sponsor:** Maria Sklodowska-Curie National Research Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-06
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380262, "Pre-emptive Low-dose Doxycycline During Anti-EGFR Treatment". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01380262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*